Ikarian Capital, LLC Compugen LTD Transaction History
Ikarian Capital, LLC
- $247 Million
- Q2 2024
A detailed history of Ikarian Capital, LLC transactions in Compugen LTD stock. As of the latest transaction made, Ikarian Capital, LLC holds 500 shares of CGEN stock, worth $820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$820% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CGEN
# of Institutions
73Shares Held
13.3MCall Options Held
191KPut Options Held
135K-
Silverarc Capital Management, LLC1.5MShares$2.46 Million0.72% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$2.11 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.2MShares$1.97 Million1.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$1.79 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.67 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $142M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...